1. Panel biomarkers associated with cancer invasion and prognostic prediction for head–neck cancer
- Author
-
Joseph Tung-Chieh Chang, Kang Hsing Fan, Chun Yu Huang, Ann-Joy Cheng, Guo Rung You, and Yin Ju Chen
- Subjects
0301 basic medicine ,Cell invasion ,Oncology ,medicine.medical_specialty ,PDGFB ,Squamous Cell Carcinoma of Head and Neck ,business.industry ,Biochemistry (medical) ,Clinical Biochemistry ,Cancer ,Head neck cancer ,medicine.disease ,Precision medicine ,Metastasis ,Transcriptome ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Internal medicine ,Drug Discovery ,Medicine ,business ,Insulin-like growth factor 1 receptor - Abstract
Aim: Cell invasion leading to metastasis is a major cause of treatment failure in head–neck cancers (HNCs). Identifying prognostic molecules associated with invasiveness is imperative for clinical applications. Materials & methods: A systemic approach was used to globally survey invasion-related genes, including transcriptomic profiling, pathway analysis, data mining and prognostic assessment using TCGA-HNSC dataset. Results: Six functional pathways and six hub molecules (LAMA3, LAMC2, THBS1, IGF1R, PDGFB and TGFβ1) were identified that significantly contributed to cell invasion, leading to poor survival in HNC patients. Combinations of multiple biomarkers substantially increased the probability of accurately predicting prognosis. Conclusion: Our six defined invasion-related molecules may be used as a panel signature in precision medicine for prognostic indicators or molecular therapeutic targets for HNC.
- Published
- 2021
- Full Text
- View/download PDF